今年9月份在德國科隆舉行的分子影像學會年會上，展示了一種熒光分子X線斷層掃描系統和光學探針設備。

美國VisEn醫學公司作為分子影像領域的先行者，分子影像領域和技術的開發商，該公司在2005年中期開始銷售其商品化前期的設備和光學探針產品。該技術具有定量功能并具有廣泛的應用范圍，VisEn公司的科學家在此次會議上展示了18篇摘要，包括在癌癥藥物測試、心血管疾病和骨骼再塑造領域的應用。

VisEn醫學公司總裁兼首席執行官Kirtland G.Poss說：“消費者對我們技術的認同接受度如此之高，我們感到十分興奮，并打算擴大我們產品的商業運輸以及使用。我們的產品是第一種能夠在動物中真正進行定量、熒光三維成像的的光學系統。”

Fluorescence Molecular Tomography System
 
A fluorescence molecular tomography (FMT) system and optical probe device were presented at the annual meeting of the Society for Molecular Imaging (SMI) in September in Cologne ( Germany).

A pioneer in the field of molecular imaging, VisEn Medical (Cambridge, MA, USA), a pioneer in the field of molecular imaging and the developer of the technology, began selling a pre-commercial version of its instrument and its line of optical probe products in the first half of 2005. Underscoring the quantitative power and broad utility of the technology, VisEn’s scientists presented a total of 18 abstracts at the SMI meeting, including those on applications in cancer drug testing, cardiovascular disease, and bone remodeling.

“We are extremely pleased by the strong customer acceptance of our technology and look forward to expanded commercial shipments and use of our instrument,” said Kirtland G. Poss, president and CEO of VisEn Medical. “Ours is the first optical system to enable truly quantitative, deep tissue, three-dimensional tomographic imaging of fluorescence in animals.